GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 232 filers reported holding GENMAB A/S in Q4 2022. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $902,912 | -1.5% | 25,600 | +6.2% | 0.16% | -13.4% |
| Q2 2023 | $916,611 | +7.3% | 24,115 | +6.6% | 0.18% | -0.6% |
| Q1 2023 | $854,282 | -12.5% | 22,624 | -1.8% | 0.18% | -9.5% |
| Q4 2022 | $976,096 | -70.7% | 23,032 | -77.3% | 0.20% | -66.8% |
| Q1 2021 | $3,333,000 | -23.7% | 101,518 | -5.5% | 0.60% | -24.3% |
| Q4 2020 | $4,368,000 | +7.9% | 107,417 | -2.9% | 0.79% | -10.5% |
| Q3 2020 | $4,050,000 | +8.3% | 110,620 | +0.2% | 0.88% | -0.6% |
| Q2 2020 | $3,740,000 | +578.8% | 110,364 | +324.1% | 0.89% | +589.1% |
| Q1 2020 | $551,000 | -14.7% | 26,024 | -10.1% | 0.13% | +24.0% |
| Q4 2019 | $646,000 | – | 28,938 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 52,148 | $1,839,260 | 1.67% |
| Ativo Capital Management LLC | 28,442 | $1,003,132 | 1.13% |
| HARDING LOEVNER LP | 3,204,230 | $113,013,183 | 0.75% |
| Hardman Johnston Global Advisors LLC | 592,318 | $20,891,056 | 0.70% |
| Yorktown Management & Research Co Inc | 16,600 | $585,482 | 0.66% |
| TORRAY INVESTMENT PARTNERS LLC | 104,516 | $3,686,279 | 0.65% |
| First Light Asset Management, LLC | 157,147 | $5,542,575 | 0.53% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 44,300 | $1,561,575 | 0.53% |
| Capricorn Fund Managers Ltd | 37,007 | $1,305,237 | 0.45% |
| Legacy Wealth Asset Management, LLC | 29,496 | $1,040,324 | 0.38% |